Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Neuropsychology Review
Published in: Neuropsychology Review 1/2019

Open Access 01-03-2019 | Addiction | Review

Efficacy of Pharmacological Interventions in Targeting Decision-Making Impairments across Substance and Behavioral Addictions

Authors: Samuel R. Chamberlain, Jon E. Grant

Published in: Neuropsychology Review | Issue 1/2019

Login to get access

Abstract

Decision-making impairments reflect tendencies towards risky or unwise choices as manifested by presence of psychiatric symptoms or cognitive impairment (e.g. representation of value, inhibitory control-response selection, learning). Such impairments are suggested by the hallmark symptoms of substance and behavioral addictions, which include escalation over time (of substance intake or a given behavior), lack of control, neglect of other domains of life, and cognitive distortions (such as ‘chasing losses’ in gambling disorder). Amongst the putative behavioral addictions, most epidemiological data exist for gambling disorder, which is now included in DSM-5 as a substance-related and addictive disorder. However, other disorders share parallels and may also constitute behavioral addictions, such as compulsive stealing (kleptomania), compulsive shopping, and compulsive sexual behavior. The current paper presents a narrative review of evidence for cognitive decision-making impairments in addictions, as well as pharmacological treatments of these disorders that may have relevance for improving decision-making. We find that objective decision-making deficits have been widely reported in patients with substance use disorders and gambling disorder, compared to controls. Decision-making in the other behavioral addictions is under-studied. Evidence-based pharmacological treatments for some of these addictive disorders, for example, opioid antagonists and glutamatergic agents, modulate neural systems playing key roles in decision-making. But clinical trials have seldom examined effects of such treatments on objective decision-making measures. Future research directions are discussed, including the need to include standardized outcome measures of decision-making (tasks and imaging) alongside traditional clinical measures, to better understand and enhance underlying treatment mechanisms.
Literature
Akbar, M., Egli, M., Cho, Y. E., Song, B. J., & Noronha, A. (2018). Medications for alcohol use disorders: An overview. Pharmacology & Therapeutics, 185, 64–85.CrossRef
Ambermoon, P., Carter, A., Hall, W. D., Dissanayaka, N. N., & O'Sullivan, J. D. (2011). Impulse control disorders in patients with Parkinson's disease receiving dopamine replacement therapy: Evidence and implications for the addictions field. Addiction, 106, 283–293.CrossRefPubMed
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.) (DSM-5). In American Psychiatric Publishing. Arlington: VA.
Amlung, M., Vedelago, L., Acker, J., Balodis, I., & MacKillop, J. (2017). Steep delay discounting and addictive behavior: A meta-analysis of continuous associations. Addiction, 112, 51–62.CrossRefPubMed
Anton, R. F., Kranzler, H., Breder, C., Marcus, R. N., Carson, W. H., & Han, J. (2008). A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence. Journal of Clinical Psychopharmacology, 28, 5–12.CrossRefPubMed
Ashok, A. H., Mizuno, Y., Volkow, N. D. & Howes, O. D. (2017). Association of Stimulant use with Dopaminergic Alterations in users of cocaine, amphetamine, or methamphetamine: A systematic review and meta-analysis. JAMA Psychiatry, 74(5), 511–519.
Berlin, H. A., Braun, A., Simeon, D., Koran, L. M., Potenza, M. N., McElroy, S. L., … Hollander, E. (2013). A double-blind, placebo-controlled trial of topiramate for pathological gambling. The World Journal of Biological Psychiatry, 14, 121–128.CrossRefPubMed
Bickel, W. K., Mellis, A. M., Snider, S. E., Athamneh, L. N., Stein, J. S., & Pope, D. A. (2018). 21st century neurobehavioral theories of decision making in addiction: Review and evaluation. Pharmacology, Biochemistry, and Behavior, 164, 4–21.CrossRefPubMed
Biernacki, K., McLennan, S. N., Terrett, G., Labuschagne, I., & Rendell, P. G. (2016). Decision-making ability in current and past users of opiates: A meta-analysis. Neuroscience and Biobehavioral Reviews, 71, 342–351.CrossRefPubMed
Black, D. W., Gabel, J., Hansen, J., & Schlosser, S. (2000). A double-blind comparison of fluvoxamine versus placebo in the treatment of compulsive buying disorder. Annals of Clinical Psychiatry, 12, 205–211.CrossRefPubMed
Blakemore, S. J., & Robbins, T. W. (2012). Decision-making in the adolescent brain. Nature Neuroscience, 15, 1184–1191.CrossRefPubMed
Blanco, C., Petkova, E., Ibanez, A., & Saiz-Ruiz, J. (2002). A pilot placebo-controlled study of fluvoxamine for pathological gambling. Annals of Clinical Psychiatry, 14, 9–15.CrossRefPubMed
Boileau, I., Payer, D., Chugani, B., Lobo, D., Behzadi, A., Rusjan, P. M., … Zack, M. (2013). The D2/3 dopamine receptor in pathological gambling: A positron emission tomography study with [(11) C]-(+)-propyl-hexahydro-naphtho-oxazin and [(11) C]raclopride. Addiction, 108, 953–963.CrossRefPubMed
Boileau, I., Payer, D., Chugani, B., Lobo, D. S., Houle, S., Wilson, A. A., … Zack, M. (2014). In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: A positron emission tomography study with [(11)C]-(+)-PHNO. Molecular Psychiatry, 19, 1305–1313.CrossRefPubMed
Bugalho, P., & Oliveira-Maia, A. J. (2013). Impulse control disorders in Parkinson's disease: Crossroads between neurology, psychiatry and neuroscience. Behavioural Neurology, 27(4), 547–557.CrossRefPubMedPubMedCentral
Chamberlain, S. R., Stochl, J., Redden, S. A., & Grant, J. E. (2017). Latent traits of impulsivity and compulsivity: Toward dimensional psychiatry. Psychological Medicine, 48, 810–821.CrossRefPubMedPubMedCentral
Clark, L. (2010). Decision-making during gambling: An integration of cognitive and psychobiological approaches. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 365, 319–330.CrossRefPubMedPubMedCentral
Clark, L., Bechara, A., Damasio, H., Aitken, M. R., Sahakian, B. J., & Robbins, T. W. (2008). Differential effects of insular and ventromedial prefrontal cortex lesions on risky decision-making. Brain, 131, 1311–1322.CrossRefPubMedPubMedCentral
Clark, L., Cools, R., & Robbins, T. W. (2004). The neuropsychology of ventral prefrontal cortex: Decision-making and reversal learning. Brain and Cognition, 55(1), 41–53.CrossRefPubMed
Clark, L., & Limbrick-Oldfield, E. H. (2013). Disordered gambling: A behavioral addiction. Current Opinion in Neurobiology, 23, 655–659.CrossRefPubMed
de Ruiter, M. B., Oosterlaan, J., Veltman, D. J., van den Brink, W., & Goudriaan, A. E. (2012). Similar hyporesponsiveness of the dorsomedial prefrontal cortex in problem gamblers and heavy smokers during an inhibitory control task. Drug and Alcohol Dependence, 121(1-2), 81–89.CrossRefPubMed
Del Campo, N., Chamberlain, S. R., Sahakian, B. J., & Robbins, T. W. (2011). The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder. Biological Psychiatry, 69, e145–e157.CrossRefPubMed
Derbyshire, K. L., Chamberlain, S. R., Odlaug, B. L., Schreiber, L. R., & Grant, J. E. (2014). Neurocognitive functioning in compulsive buying disorder. Annals of Clinical Psychiatry, 26, 57–63.PubMed
Derbyshire, K. L., & Grant, J. E. (2015). Neurocognitive findings in compulsive sexual behavior: A preliminary study. Journal of Behavioral Addictions, 4, 35–36.CrossRefPubMedPubMedCentral
DeVito, E. E., Blackwell, A. D., Kent, L., Ersche, K. D., Clark, L., Salmond, C. H., … Sahakian, B. J. (2008). The effects of methylphenidate on decision making in attention-deficit/hyperactivity disorder. Biological Psychiatry, 64, 636–639.CrossRefPubMedPubMedCentral
Ersche, K. D., Williams, G. B., Robbins, T. W., & Bullmore, E. T. (2013). Meta-analysis of structural brain abnormalities associated with stimulant drug dependence and neuroimaging of addiction vulnerability and resilience. Current Opinion in Neurobiology, 23, 615–624.CrossRefPubMed
Fellows, L. K., & Farah, M. J. (2005). Different underlying impairments in decision-making following ventromedial and dorsolateral frontal lobe damage in humans. Cerebral Cortex, 15, 58–63.CrossRefPubMed
Fong, T., Kalechstein, A., Bernhard, B., Rosenthal, R., & Rugle, L. (2008). A double-blind, placebo-controlled trial of olanzapine for the treatment of video poker pathological gamblers. Pharmacology, Biochemistry, and Behavior, 89, 298–303.CrossRefPubMed
Goodie, A. S., & Fortune, E. E. (2013). Measuring cognitive distortions in pathological gambling: Review and meta-analyses. Psychology of Addictive Behaviors, 27, 730–743.CrossRefPubMed
Goodman, A. (1993). Diagnosis and treatment of sexual addiction. Journal of Sex & Marital Therapy, 19, 225–251.CrossRef
Goodman, A. (2008). Neurobiology of addiction. An integrative review. Biochem Pharmacol, 75, 266–322.CrossRefPubMed
Goudriaan, A. E., Yucel, M., & van Holst, R. J. (2014). Getting a grip on problem gambling: What can neuroscience tell us? Frontiers in Behavioral Neuroscience, 8, 141.CrossRefPubMedPubMedCentral
Grant, J. E., Brewer, J. A., & Potenza, M. N. (2006). The neurobiology of substance and behavioral addictions. CNS Spectrums, 11, 924–930.CrossRefPubMed
Grant, J. E., Chamberlain, S. R., & Odlaug, B. L. (2014). Clinical guide to obsessive compulsive and related disorders. New York, USA: Oxford University Press.CrossRef
Grant, J. E., Chamberlain, S. R., Schreiber, L. R., & Odlaug, B. L. (2012). Neurocognitive deficits associated with shoplifting in young adults. Comprehensive Psychiatry, 53(8), 1049–1055.CrossRefPubMed
Grant, J. E., Chamberlain, S. R., Schreiber, L. R., Odlaug, B. L., & Kim, S. W. (2011). Selective decision-making deficits in at-risk gamblers. Psychiatry Research, 189(1), 115–120.CrossRefPubMedPubMedCentral
Grant, J. E., Kim, S. W., & Hartman, B. K. (2008). A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges. The Journal of Clinical Psychiatry, 69, 783–789.CrossRefPubMed
Grant, J. E., Kim, S. W., & Odlaug, B. L. (2007). N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: A pilot study. Biological Psychiatry, 62, 652–657.CrossRefPubMed
Grant, J. E., Kim, S. W., & Odlaug, B. L. (2009). A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of kleptomania. Biological Psychiatry, 65, 600–606.CrossRefPubMed
Grant, J. E., Kim, S. W., Potenza, M. N., Blanco, C., Ibanez, A., Stevens, L., … Zaninelli, R. (2003). Paroxetine treatment of pathological gambling: A multi-Centre randomized controlled trial. International Clinical Psychopharmacology, 18, 243–249.CrossRefPubMed
Grant, J. E., Odlaug, B. L., & Chamberlain, S. R. (2015). Reduced cortical thickness in gambling disorder: A morphometric MRI study. European Archives of Psychiatry and Clinical Neuroscience, 265, 655–661.CrossRefPubMed
Grant, J. E., Odlaug, B. L., Chamberlain, S. R., Hampshire, A., Schreiber, L. R., & Kim, S. W. (2013). A proof of concept study of tolcapone for pathological gambling: Relationships with COMT genotype and brain activation. European Neuropsychopharmacology, 23, 1587–1596.CrossRefPubMed
Grant, J. E., Odlaug, B. L., Chamberlain, S. R., Potenza, M. N., Schreiber, L. R., Donahue, C. B., & Kim, S. W. (2014). A randomized, placebo-controlled trial of N-acetylcysteine plus imaginal desensitization for nicotine-dependent pathological gamblers. The Journal of Clinical Psychiatry, 75, 39–45.CrossRefPubMed
Grant, J. E., Odlaug, B. L., Mooney, M., O'Brien, R., & Kim, S. W. (2012). Open-label pilot study of memantine in the treatment of compulsive buying. Annals of Clinical Psychiatry, 24, 119–126.PubMed
Grant, J. E., Odlaug, B. L., Potenza, M. N., Hollander, E., & Kim, S. W. (2010). Nalmefene in the treatment of pathological gambling: Multicentre, double-blind, placebo-controlled study. The British Journal of Psychiatry, 197, 330–331.CrossRefPubMed
Grant, J. E., Odlaug, B. L., Schreiber, L. R., Chamberlain, S. R., & Won Kim, S. (2013). Memantine reduces stealing behavior and impulsivity in kleptomania: A pilot study. International Clinical Psychopharmacology, 28, 106–111.CrossRefPubMed
Grant, J. E., Potenza, M. N., Hollander, E., Cunningham-Williams, R., Nurminen, T., Smits, G., & Kallio, A. (2006). Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. The American Journal of Psychiatry, 163, 303–312.CrossRefPubMed
Guttman, Z., Moeller, S. J., & London, E. D. (2018). Neural underpinnings of maladaptive decision-making in addictions. Pharmacology, Biochemistry, and Behavior, 164, 84–98.CrossRefPubMed
Hollander, E., DeCaria, C. M., Finkell, J. N., Begaz, T., Wong, C. M., & Cartwright, C. (2000). A randomized double-blind fluvoxamine/placebo crossover trial in pathologic gambling. Biological Psychiatry, 47, 813–817.CrossRefPubMed
Holt, S. R., & Tobin, D. G. (2018). Pharmacotherapy for alcohol use disorder. The Medical Clinics of North America, 102, 653–666.CrossRefPubMed
Jonas, D. E., Amick, H. R., Feltner, C., Bobashev, G., Thomas, K., Wines, R., … Garbutt, J. C. (2014). Pharmacotherapy for adults with alcohol use disorders in outpatient settings: A systematic review and meta-analysis. JAMA, 311, 1889–1900.CrossRefPubMed
Kalivas, P. W., Lalumiere, R. T., Knackstedt, L., & Shen, H. (2009). Glutamate transmission in addiction. Neuropharmacology, 56(Suppl 1), 169–173.CrossRefPubMed
Kehagia, A. A., Housden, C. R., Regenthal, R., Barker, R. A., Muller, U., Rowe, J., … Robbins, T. W. (2014). Targeting impulsivity in Parkinson's disease using atomoxetine. Brain, 137, 1986–1997.CrossRefPubMedPubMedCentral
Kim, S. W., Grant, J. E., Adson, D. E., & Shin, Y. C. (2001). Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biological Psychiatry, 49, 914–921.CrossRefPubMed
Kim, S. W., Grant, J. E., Adson, D. E., Shin, Y. C., & Zaninelli, R. (2002). A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling. The Journal of Clinical Psychiatry, 63(6), 501–507.CrossRefPubMed
Koffarnus, M. N., & Kaplan, B. A. (2018). Clinical models of decision making in addiction. Pharmacology, Biochemistry, and Behavior, 164, 71–83.CrossRefPubMed
Koran, L. M., Aboujaoude, E. N., & Gamel, N. N. (2007). Escitalopram treatment of kleptomania: An open-label trial followed by double-blind discontinuation. The Journal of Clinical Psychiatry, 68, 422–427.CrossRefPubMed
Koran, L. M., Aboujaoude, E. N., Solvason, B., Gamel, N. N., & Smith, E. H. (2007). Escitalopram for compulsive buying disorder: A double-blind discontinuation study. Journal of Clinical Psychopharmacology, 27, 225–227.CrossRefPubMed
Kovacs, I., Richman, M. J., Janka, Z., Maraz, A., & Ando, B. (2017). Decision making measured by the Iowa gambling task in alcohol use disorder and gambling disorder: A systematic review and meta-analysis. Drug and Alcohol Dependence, 181, 152–161.CrossRefPubMed
Kyonka, E. G. E., & Schutte, N. S. (2018). Probability discounting and gambling: A meta-analysis. Addiction., 113(12), 2173–2181.CrossRefPubMed
Littleton, J., & Zieglgansberger, W. (2003). Pharmacological mechanisms of naltrexone and acamprosate in the prevention of relapse in alcohol dependence. The American Journal on Addictions, 12(Suppl 1), S3–S11.
Luijten, M., Schellekens, A. F., Kuhn, S., Machielse, M. W. & Sescousse, G. (2017). Disruption of reward processing in addiction : An image-based meta-analysis of functional magnetic resonance imaging studies. JAMA Psychiatry, 74(4), 387–398.
MacKillop, J., Amlung, M. T., Few, L. R., Ray, L. A., Sweet, L. H., & Munafo, M. R. (2011). Delayed reward discounting and addictive behavior: A meta-analysis. Psychopharmacology, 216, 305–321.CrossRefPubMedPubMedCentral
Manes, F., Sahakian, B., Clark, L., Rogers, R., Antoun, N., Aitken, M., & Robbins, T. (2002). Decision-making processes following damage to the prefrontal cortex. Brain, 125, 624–639.CrossRefPubMed
Martinotti, G., Di Nicola, M., Di Giannantonio, M., & Janiri, L. (2009). Aripiprazole in the treatment of patients with alcohol dependence: A double-blind, comparison trial vs. naltrexone. Journal of Psychopharmacology, 23, 123–129.CrossRefPubMed
Martinotti, G., Orsolini, L., Fornaro, M., Vecchiotti, R., De Berardis, D., Iasevoli, F., … Di Giannantonio, M. (2016). Aripiprazole for relapse prevention and craving in alcohol use disorder: Current evidence and future perspectives. Expert Opinion on Investigational Drugs, 25, 719–728.CrossRefPubMed
McElroy, S. L., Nelson, E. B., Welge, J. A., Kaehler, L., & Keck, P. E., Jr. (2008). Olanzapine in the treatment of pathological gambling: A negative randomized placebo-controlled trial. The Journal of Clinical Psychiatry, 69, 433–440.CrossRefPubMed
McLean, A., Rubinsztein, J. S., Robbins, T. W., & Sahakian, B. J. (2004). The effects of tyrosine depletion in normal healthy volunteers: Implications for unipolar depression. Psychopharmacology, 171, 286–297.CrossRefPubMed
Ninan, P. T., McElroy, S. L., Kane, C. P., Knight, B. T., Casuto, L. S., Rose, S. E., … Nemeroff, C. B. (2000). Placebo-controlled study of fluvoxamine in the treatment of patients with compulsive buying. Journal of Clinical Psychopharmacology, 20, 362–366.CrossRefPubMed
Poletti, M., Logi, C., Lucetti, C., Del Dotto, P., Baldacci, F., Vergallo, A., … Bonuccelli, U. (2013). A single-center, cross-sectional prevalence study of impulse control disorders in Parkinson disease: Association with dopaminergic drugs. Journal of Clinical Psychopharmacology, 33, 691–694.CrossRefPubMed
Preuschoff, K., Bossaerts, P., & Quartz, S. R. (2006). Neural differentiation of expected reward and risk in human subcortical structures. Neuron, 51, 381–390.CrossRefPubMed
Rahman, S., Robbins, T. W., Hodges, J. R., Mehta, M. A., Nestor, P. J., Clark, L., & Sahakian, B. J. (2006). Methylphenidate ('Ritalin') can ameliorate abnormal risk-taking behavior in the frontal variant of frontotemporal dementia. Neuropsychopharmacology, 31, 651–658.CrossRefPubMed
Rahman, S., Sahakia, J. B., Cardinal, N. R., Rogers, R., & Robbins, T. (2001). Decision making and neuropsychiatry. Trends in Cognitive Sciences, 5, 271–277.CrossRefPubMed
Reus, V. I., Fochtmann, L. J., Bukstein, O., Eyler, A. E., Hilty, D. M., Horvitz-Lennon, M., … Hong, S. H. (2018). The American Psychiatric Association practice guideline for the pharmacological treatment of patients with alcohol use disorder. The American Journal of Psychiatry, 175, 86–90.CrossRefPubMed
Rogers, R. D., Everitt, B. J., Baldacchino, A., Blackshaw, A. J., Swainson, R., Wynne, K., … Robbins, T. W. (1999). Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: Evidence for monoaminergic mechanisms. Neuropsychopharmacology, 20, 322–339.CrossRefPubMed
Roiser, J. P., McLean, A., Ogilvie, A. D., Blackwell, A. D., Bamber, D. J., Goodyer, I., … Sahakian, B. J. (2005). The subjective and cognitive effects of acute phenylalanine and tyrosine depletion in patients recovered from depression. Neuropsychopharmacology, 30, 775–785.CrossRefPubMed
Roxanas, M. G. (2010). Pathological gambling and compulsive eating associated with aripiprazole. The Australian and New Zealand Journal of Psychiatry, 44, 291.CrossRefPubMed
Saiz-Ruiz, J., Blanco, C., Ibanez, A., Masramon, X., Gomez, M. M., Madrigal, M., & Diez, T. (2005). Sertraline treatment of pathological gambling: A pilot study. The Journal of Clinical Psychiatry, 66, 28–33.CrossRefPubMed
Scott-Sheldon, L. A., Carey, K. B., Cunningham, K., Johnson, B. T., Carey, M. P., & Team, M. R. (2016). Alcohol use predicts sexual decision-making: A systematic review and meta-analysis of the experimental literature. AIDS and Behavior, 20(Suppl 1), S19–S39.CrossRefPubMed
Simon, N. W., Montgomery, K. S., Beas, B. S., Mitchell, M. R., LaSarge, C. L., Mendez, I. A., … Setlow, B. (2011). Dopaminergic modulation of risky decision-making. The Journal of Neuroscience, 31, 17460–17470.CrossRefPubMedPubMedCentral
Talbot, P. S., Watson, D. R., Barrett, S. L., & Cooper, S. J. (2006). Rapid tryptophan depletion improves decision-making cognition in healthy humans without affecting reversal learning or set shifting. Neuropsychopharmacology, 31, 1519–1525.CrossRefPubMed
van den Brink, W. (2012). Evidence-based pharmacological treatment of substance use disorders and pathological gambling. Current Drug Abuse Reviews, 5, 3–31.CrossRefPubMed
van Timmeren, T., Daams, J. G., van Holst, R. J., & Goudriaan, A. E. (2018). Compulsivity-related neurocognitive performance deficits in gambling disorder: A systematic review and meta-analysis. Neuroscience and Biobehavioral Reviews, 84, 204–217.CrossRefPubMed
Verdejo-Garcia, A., Chong, T. T., Stout, J. C., Yucel, M., & London, E. D. (2017). Stages of dysfunctional decision-making in addiction. Pharmacology, Biochemistry, and Behavior, 164, 99–105.
Verdejo-Garcia, A., Lawrence, A. J., & Clark, L. (2008). Impulsivity as a vulnerability marker for substance-use disorders: Review of findings from high-risk research, problem gamblers and genetic association studies. Neuroscience and Biobehavioral Reviews, 32, 777–810.CrossRefPubMed
Vetulani, J. (2001). Drug addiction. Part II. Neurobiology of addiction. Polish Journal of Pharmacology, 53, 303–317.CrossRefPubMed
Volkow, N. D., Fowler, J. S., & Wang, G. J. (2004). The addicted human brain viewed in the light of imaging studies: Brain circuits and treatment strategies. Neuropharmacology, 47(Suppl 1), 3–13.CrossRefPubMed
Wainberg, M. L., Muench, F., Morgenstern, J., Hollander, E., Irwin, T. W., Parsons, J. T., … O'Leary, A. (2006). A double-blind study of citalopram versus placebo in the treatment of compulsive sexual behaviors in gay and bisexual men. The Journal of Clinical Psychiatry, 67, 1968–1973.CrossRefPubMed
Yan, W. S., Li, Y. H., Xiao, L., Zhu, N., Bechara, A., & Sui, N. (2014). Working memory and affective decision-making in addiction: A neurocognitive comparison between heroin addicts, pathological gamblers and healthy controls. Drug and Alcohol Dependence, 134, 194–200.CrossRefPubMed
Zack, M., & Poulos, C. X. (2009). Effects of the atypical stimulant modafinil on a brief gambling episode in pathological gamblers with high vs. low impulsivity. Journal of Psychopharmacology, 23, 660–671.CrossRefPubMed
Zois, E., Kiefer, F., Lemenager, T., Vollstadt-Klein, S., Mann, K., & Fauth-Buhler, M. (2017). Frontal cortex gray matter volume alterations in pathological gambling occur independently from substance use disorder. Addiction Biology, 22, 864–872.CrossRefPubMed
Metadata
Title
Efficacy of Pharmacological Interventions in Targeting Decision-Making Impairments across Substance and Behavioral Addictions
Authors
Samuel R. Chamberlain
Jon E. Grant
Publication date
01-03-2019
Publisher
Springer US
Published in
Neuropsychology Review / Issue 1/2019
Print ISSN: 1040-7308
Electronic ISSN: 1573-6660
DOI
https://doi.org/10.1007/s11065-019-09400-z

Other articles of this Issue 1/2019

Neuropsychology Review 1/2019 Go to the issue

Review

Neuropsychological Interventions for Decision-Making in Addiction: a Systematic Review

Review

A Systematic Meta-Review of Impulsivity and Compulsivity in Addictive Behaviors

Review

Let’s Open the Decision-Making Umbrella: A Framework for Conceptualizing and Assessing Features of Impaired Decision Making in Addiction

Review

Cognitive Bias Modification for Behavior Change in Alcohol and Smoking Addiction: Bayesian Meta-Analysis of Individual Participant Data

Review

Efficacy of Invasive and Non-Invasive Brain Modulation Interventions for Addiction

Review

A Patient-Tailored Evidence-Based Approach for Developing Early Neuropsychological Training Programs in Addiction Settings